Cargando…
A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib
Envenomation by elapid snakes primarily results in neurotoxic symptoms and, consequently, are the primary focus of therapeutic research concerning such venoms. However, mounting evidence suggests these venoms can additionally cause coagulopathic symptoms, as demonstrated by some Asian elapids and Af...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695013/ https://www.ncbi.nlm.nih.gov/pubmed/36355986 http://dx.doi.org/10.3390/toxins14110736 |
_version_ | 1784837950382538752 |
---|---|
author | Arrahman, Arif Kazandjian, Taline D. Still, Kristina B. M. Slagboom, Julien Somsen, Govert W. Vonk, Freek J. Casewell, Nicholas R. Kool, Jeroen |
author_facet | Arrahman, Arif Kazandjian, Taline D. Still, Kristina B. M. Slagboom, Julien Somsen, Govert W. Vonk, Freek J. Casewell, Nicholas R. Kool, Jeroen |
author_sort | Arrahman, Arif |
collection | PubMed |
description | Envenomation by elapid snakes primarily results in neurotoxic symptoms and, consequently, are the primary focus of therapeutic research concerning such venoms. However, mounting evidence suggests these venoms can additionally cause coagulopathic symptoms, as demonstrated by some Asian elapids and African spitting cobras. This study sought to investigate the coagulopathic potential of venoms from medically important elapids of the genera Naja (true cobras), Hemachatus (rinkhals), and Dendroaspis (mambas). Crude venoms were bioassayed for coagulant effects using a plasma coagulation assay before RPLC/MS was used to separate and identify venom toxins in parallel with a nanofractionation module. Subsequently, coagulation bioassays were performed on the nanofractionated toxins, along with in-solution tryptic digestion and proteomics analysis. These experiments were then repeated on both crude venoms and on the nanofractionated venom toxins with the addition of either the phospholipase A(2) (PLA(2)) inhibitor varespladib or the snake venom metalloproteinase (SVMP) inhibitor marimastat. Our results demonstrate that various African elapid venoms have an anticoagulant effect, and that this activity is significantly reduced for cobra venoms by the addition of varespladib, though this inhibitor had no effect against anticoagulation caused by mamba venoms. Marimastat showed limited capacity to reduce anticoagulation in elapids, affecting only N. haje and H. haemachatus venom at higher doses. Proteomic analysis of nanofractionated toxins revealed that the anticoagulant toxins in cobra venoms were both acidic and basic PLA(2)s, while the causative toxins in mamba venoms remain uncertain. This implies that while PLA(2) inhibitors such as varespladib and metalloproteinase inhibitors such as marimastat are viable candidates for novel snakebite treatments, they are not likely to be effective against mamba envenomings. |
format | Online Article Text |
id | pubmed-9695013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96950132022-11-26 A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib Arrahman, Arif Kazandjian, Taline D. Still, Kristina B. M. Slagboom, Julien Somsen, Govert W. Vonk, Freek J. Casewell, Nicholas R. Kool, Jeroen Toxins (Basel) Article Envenomation by elapid snakes primarily results in neurotoxic symptoms and, consequently, are the primary focus of therapeutic research concerning such venoms. However, mounting evidence suggests these venoms can additionally cause coagulopathic symptoms, as demonstrated by some Asian elapids and African spitting cobras. This study sought to investigate the coagulopathic potential of venoms from medically important elapids of the genera Naja (true cobras), Hemachatus (rinkhals), and Dendroaspis (mambas). Crude venoms were bioassayed for coagulant effects using a plasma coagulation assay before RPLC/MS was used to separate and identify venom toxins in parallel with a nanofractionation module. Subsequently, coagulation bioassays were performed on the nanofractionated toxins, along with in-solution tryptic digestion and proteomics analysis. These experiments were then repeated on both crude venoms and on the nanofractionated venom toxins with the addition of either the phospholipase A(2) (PLA(2)) inhibitor varespladib or the snake venom metalloproteinase (SVMP) inhibitor marimastat. Our results demonstrate that various African elapid venoms have an anticoagulant effect, and that this activity is significantly reduced for cobra venoms by the addition of varespladib, though this inhibitor had no effect against anticoagulation caused by mamba venoms. Marimastat showed limited capacity to reduce anticoagulation in elapids, affecting only N. haje and H. haemachatus venom at higher doses. Proteomic analysis of nanofractionated toxins revealed that the anticoagulant toxins in cobra venoms were both acidic and basic PLA(2)s, while the causative toxins in mamba venoms remain uncertain. This implies that while PLA(2) inhibitors such as varespladib and metalloproteinase inhibitors such as marimastat are viable candidates for novel snakebite treatments, they are not likely to be effective against mamba envenomings. MDPI 2022-10-27 /pmc/articles/PMC9695013/ /pubmed/36355986 http://dx.doi.org/10.3390/toxins14110736 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Arrahman, Arif Kazandjian, Taline D. Still, Kristina B. M. Slagboom, Julien Somsen, Govert W. Vonk, Freek J. Casewell, Nicholas R. Kool, Jeroen A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib |
title | A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib |
title_full | A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib |
title_fullStr | A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib |
title_full_unstemmed | A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib |
title_short | A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib |
title_sort | combined bioassay and nanofractionation approach to investigate the anticoagulant toxins of mamba and cobra venoms and their inhibition by varespladib |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695013/ https://www.ncbi.nlm.nih.gov/pubmed/36355986 http://dx.doi.org/10.3390/toxins14110736 |
work_keys_str_mv | AT arrahmanarif acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT kazandjiantalined acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT stillkristinabm acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT slagboomjulien acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT somsengovertw acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT vonkfreekj acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT casewellnicholasr acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT kooljeroen acombinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT arrahmanarif combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT kazandjiantalined combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT stillkristinabm combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT slagboomjulien combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT somsengovertw combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT vonkfreekj combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT casewellnicholasr combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib AT kooljeroen combinedbioassayandnanofractionationapproachtoinvestigatetheanticoagulanttoxinsofmambaandcobravenomsandtheirinhibitionbyvarespladib |